Browsing: reimbursement

Summary of various healthcare finance news articles

AdvaMed outlines key principles to promote broader access to digital health technologies, including AI/ML, and FDA-regulated innovations.

Pharming’s Joenja, a treatment for APDS, has been approved for reimbursement in England after NICE reversed its earlier rejection. The EU regulatory review is still ongoing.

This article explores the common obstacles hindering the progress of health tech products and provides insights on how to overcome these barriers and achieve market success.